Abstract
We analyzed 212 group B streptococci (GBS) from invasive infections in newborns in the Barcelona area between 1992-2009, with the aim of documenting changes in the prevalence of serotypes, antimicrobial resistance and genetic lineages and evaluating their association with either early-onset (EOD) or late-onset disease (LOD). Serotypes 5 III (n=118) and Ia (n=47) together accounted for nearly 78% of the isolates. All isolates carried an alpha or alpha-like protein gene, with specific associations between genes and serotypes such as, Ib/bca, II/bca, III/rib and V/alp3, reflecting the presence of particular genetic lineages. Macrolide resistance (14.2%) was significantly associated to serotype V. Pulsed-field gel electrophoresis (PFGE) clustering was an excellent 10 predictor of serotype and antibiotic resistance. The combination of PFGE and multilocus sequence typing revealed a large number of genetically distinct lineages.
Still, specific lineages were dominant in our collection, particularly the serotype III/ST17/rib that had enhanced potential to cause LOD. Serotype Ia was concentrated on a single PFGE cluster composed of two genetic lineages: ST23/eps and ST24/bca. The 15 ST24/bca sub-lineage of serotype Ia, that is infrequently found elsewhere, may be emerging as an important cause of neonatal invasive infections in the Mediterranean region. In spite of the introduction of prophylaxis, resulting in a pronounced decline of EOD, the study revealed a remarkably stable clonal structure of GBS causing neonatal infections in Barcelona in a period of 18 years. 20
Introduction
Streptococcus agalactiae, or group B streptococcus (GBS) is well established as a leading cause of neonatal sepsis and meningitis (25, 45) . In neonates, early-onset disease (EOD) is defined as occurring within the first 7 days and late-onset disease (LOD) from day 8 to 90 (12). While vertical transmission is commonly accepted to be 5 the cause of EOD (24, 37, 51) , the source of bacterial strains causing LOD is less well understood (45) . In 1996 guidelines for prevention of GBS neonatal infections by antimicrobial prophylaxis were published in the United States (12). Whereas a mixed risk-based and screening-based approach was initially suggested in the guidelines, shortly after the universal screening of pregnant women for GBS vaginal colonization at 10 35 to 37 weeks of gestation and the administration of intrapartum antimicrobial prophylaxis to carriers was proposed (11). As a consequence, the incidence of EOD where these guidelines were followed has fallen significantly over the past decade, yet this strategy is raising concern as to the widespread use of intrapartum antimicrobials that might delay, rather than prevent, GBS disease onset (10, 16). In the area of 15 Barcelona, during the implementation of the intrapartum antimicrobial prophylaxis guidelines the incidence of EOD declined by 86% from 1 these values, these changes did not reflect a significant trend.
Furthermore, the increase in antimicrobial use due to intrapartum antibiotic prophylaxis can lead to the emergence of resistant bacteria (46) , a concern that has been strengthened by the recent description of GBS strains showing reduced susceptibility to beta-lactams (28). 25 4 These considerations are driving the search for alternative prevention strategies. Studies evaluating the potential impact of vaccines in the management of GBS disease suggest that vaccination may provide additional benefits over antimicrobial prophylaxis, especially due to the expected reduction in LOD (49). Vaccine formulations currently on trial are based on the GBS capsular polysaccharides however; they are not expected 5 to provide optimal coverage in different regions due to geographical variations in serotype distribution. In order to overcome serotype-specificity, whole-genome based approaches have been directed towards identifying protein antigens, holding promise as components of globally effective vaccines (26, 33).
In addition to the capsular polysaccharides, multiple virulence factors have been 10 recognized and extensively characterized in the past decades. These virulence factors may be unevenly distributed within a particular serotype and may contribute significantly to the invasive potential of a particular lineage, independently of its capsular polysaccharide. Molecular epidemiology has been used to discriminate genetic lineages in order to probe for associations between specific GBS genotypes and disease. 15 Most of these studies using multilocus sequence typing (MLST), have identified a lineage with enhanced invasive capacity expressing serotype III and defined by sequence type 17 (ST17) (6, 15, 31). Moreover, in a study of carriage and invasive isolates from Portugal, we found that serotype Ia presented an enhanced invasive disease potential and that it was particularly associated with EOD (36). In that study, 20 serotype Ia was associated mostly with a single pulsed-field gel electrophoresis (PFGE) cluster and with two sequence types (ST23 and ST24), again pointing to the possible existence of particular genetic lineages with enhanced invasive disease potential.
We undertook the analysis of GBS isolates responsible for invasive infections in newborns in the Barcelona area from 1992 to 2009 with the aim of documenting 25 subclass] and mef genes, as described elsewhere (17) .
5
Pulsed-field gel profiling and MLST. Total bacterial DNA of the strains was isolated, digested with SmaI, and separated by PFGE as previously described (36). Whenever a complete digestion with SmaI was not achieved, the isoschizomer Cfr9I was used (48) . PFGE patterns were compared by using Bionumerics software (Applied Maths, SintMartens-Latem, Belgium) to create dendrograms by the unweighted pair-group method 10 with arithmetic averages (UPGMA). The Dice similarity coefficient was used with optimization and position tolerance settings of 1.0 and 1.5, respectively. PFGE-based clusters were defined as isolates with ≥80% relatedness on the dendrogram (36). MLST was performed by sequencing seven housekeeping genes as described previously (27) and sequence type (ST) identification was done by using the S. agalactiae MLST 15 database (http://pubmlst.org/sagalactiae) and analyzed using the entire database and goeBURST (20). Alleles and sequence types not previously described were deposited at the S. agalactiae MLST database. Analysis of DNA sequences was done by using the Bionumerics software. Table 1 . Serotypes III (n=118) and Ia (n=47) were the most frequent among the population, together accounting for 77.8% of the isolates. The serotypes were also differently distributed in EOD and LOD (p=0.0067, Fisher's exact 5 test). Serotypes III and Ia were found in 44% and 26%, respectively of the cases of EOD and in 72% and 17%, respectively of the cases of LOD. In fact, the number of serotype III isolates found in LOD (n=64) more than doubled the sum of all other serotypes (n=25), and this was the only serotype that showed a significant association with disease presentation (OR=2.980, CI 95% 1.581 to 5.734, indicating an association with LOD). 10
Although there were more isolates recovered from the CSF in cases of LOD (n=25) than in EOD (n=21), similarly to what was described previously (36), we did not find an association between serotype and the biological product from which the isolate was recovered.
15
PFGE cluster analysis and MLST. All isolates were analyzed by PFGE and 43 different profiles were identified, grouped into 18 different PFGE clusters (≥3 isolates), of which the major five accounted for nearly 60% of the isolates (figure 1). The remaining isolates (n=34) were included in minor PFGE groups (≤2 isolates) or had Surface protein genes were differently distributed across PFGE clusters (Figure 2 ), correlating to the proportion of serotypes within the clusters. A main exception was serotype Ia isolates that grouped in PFGE cluster H 38 regardless of presenting with surface protein gene eps or bca. In this cluster, an absolute association was found 20 between ST and the surface protein gene, with all ST23 isolates carrying the eps gene and all ST24 isolates exclusively the bca gene, in support of our hypothesis that they constitute sub-lineages. In addition, we have also identified two isolates, one representing ST223 and the other the newly identified ST545, which are SLVs of ST23 but not of ST24, and both harboring the eps gene, suggesting diversification of ST23 25 on September 13, 2017 by guest http://jcm.asm.org/
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Discussion
This study comprises a considerable number of invasive GBS isolates collected over an 18-year period in the Barcelona region. In spite of the overall large number of isolates, the number of yearly infections was low, preventing a detailed evaluation of the temporal changes of serotypes or PFGE clusters. Still, serotype III was present in all 5 years and serotype Ia was absent in only two years of the study period. The remaining serotypes were represented by fewer isolates than the number of years studied, but there was an overall correlation between the number of isolates and the number of years in which they were found (r= 0.964, p=0.0028, Spearman's test), indicating that no significant changes in the serotypes causing neonatal infections occurred in Barcelona 10 in the 18 years studied. A similar analysis by PFGE cluster is complicated by their larger number, still each of the five largest clusters (n≥10) was found in at least seven years and the two largest (A 53 and H 38 ) were found in all but two of the study years.
Taken together these data reveal a remarkably stable clonal structure of the GBS causing neonatal infections in Barcelona in a period of 18 years. This occurred in spite 15 of the major epidemiological changes in GBS neonatal infections due to the introduction of prophylaxis in 1994 that resulted in a pronounced decline in EOD (2).
We found substantial diversity among the GBS isolates causing neonatal invasive disease, not only in terms of capsular polysaccharides, but also in genetic lineages defined by both PFGE and MLST (figure 2 and Table 2 ). However, most isolates 20 belonged to two serotypes and to a few STs and major PFGE clusters. The serotype distribution found in the population was similar to that described in some European countries, where capsular types Ia and III prevail among isolates causing neonatal invasive infections (5, 36, 41). In contrast to some US studies, where the prevalence of serotype V goes up to 30% (42) , and to its recent increase reported in Scandinavia (4, 25 on September 13, 2017 by guest http://jcm.asm.org/ Downloaded from 39), in Barcelona serotype V was much less frequently found, similarly to most studies across Europe.
Classification by PFGE and MLST defined groups of isolates frequently sharing the same serotype and surface protein gene, indicating that both techniques are identifying groups of closely related isolates. A strong correlation between the genes encoding 5 surface proteins and the serotype was also found (Table 3) , with most serotypes associated primarily with a single surface protein gene. The exception was serotype Ia that was associated with two proteins, although only one reached significance, with approximately a quarter of the isolates carrying the bca gene and the remaining three quarters carrying the eps gene. While our data is consistent with that described in 10 Europe, contrasting data can be found in some studies from the U.S. that report the absence of the bca surface protein gene in all serotype Ia isolates causing neonatal invasive infections (32). We believe that this is a defining characteristic of a sub-lineage of serotype Ia, as discussed below. Also in contrast to the data reported here, another study from the U.S. found the bca surface protein gene as the most prevalent in serotype 15 V isolates (50) . Considering that most studies describe a strong association of serotype V with the alp3 gene (21, 29, 43) , it is possible that the higher prevalence of serotype V in the U.S. when compared to Europe results from the expansion of a sub-lineage not found in Europe. This despite most serotype V isolates in either continent sharing the same sequence type (ST1). In spite of the recent description of penicillin non-susceptibility among GBS (28) and the intensive use of β-lactams in prophylaxis in Barcelona since 1994, all isolates were 5 fully susceptible to penicillin. The macrolides can also be used in chemoprophylaxis and in contrast to penicillin, a significant proportion of erythromycin resistance was found (14.2%) in line with previous results from a multicentre study in Spain (13.7%) (22) . The phenotypes and genotypes of macrolide resistant isolates from Barcelona were also similar to those previously identified in Spain (23) . Similarly to other studies in 10 different geographic regions, we found an association between macrolide resistance, serotype V (7, 53), and ST1 (44) . Still, only 30% of erythromycin resistance was found in serotype V, while the remaining was dispersed in all other serotypes except serotype IV, a situation observed in a few previous studies (18, 30, 52). Resistance was also found to be dispersed in many genetic lineages as defined by PFGE and MLST, in 15 agreement with the methylase genes being carried in mobile genetic elements. However, clonal expansion is also important in macrolide resistance; since PFGE cluster Q 11 , expressing serotype V and ST1 was found to be significantly associated with resistance.
On the other hand, cluster A 53 representing the highly virulent ST17 and associated lineages, was less resistant than expected, reflecting the general observation that isolates 20 representing ST17 are rarely macrolide resistant. The reasons why this highly virulent and successful lineage is seldom resistant is unknown. 
